Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 0.0882M
June 30, 2026 -4.103M
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -0.0611M
September 30, 2023 6.623M
June 30, 2023 7.837M
March 31, 2023 2.141M
December 31, 2022 5.076M
September 30, 2022 -2.704M
June 30, 2022 -15.39M
March 31, 2022 -2.798M
December 31, 2021 0.4624M
September 30, 2021 -0.0017M
June 30, 2021 -0.0022M
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 -0.7676M
Date Value
June 30, 2020 -0.0014M
March 31, 2020 0.769M
December 31, 2019 -0.689M
September 30, 2019 -1.568M
June 30, 2019 -0.3768M
March 31, 2019 -0.64M
December 31, 2018 -4.020M
September 30, 2018 -0.7693M
June 30, 2018 -2.263M
March 31, 2018 -1.976M
December 31, 2017 -2.561M
September 30, 2017 -0.776M
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 -5.440M
September 30, 2015 -0.0872M
June 30, 2015 -0.2479M
March 31, 2015 -0.6293M
December 31, 2014 -0.1209M
September 30, 2014 1.730M
June 30, 2014 1.772M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -6.00M
Capricor Therapeutics, Inc. 59.90M
Ocugen, Inc. -59.77M
Cue Biopharma, Inc. 0.00
Yarrow Bioscience, Inc. -5.00M